To secure a rapid and sufficient supply of vaccines and medicines, the global south has asked for a waiver of intellectual property rights. But despite the gravity of the situation, that is rejected outright by the EU. That should not come as a surprise. A briefing from CEO outlines the EU's traditional role as a staunch defender of big pharma monopolies, and how the push for provisions on 'data exclusivity' in trade agreements with third countries have seeked to undermine even existing flexibility under international rules.

Chemical giant's lobbyists woo MEPs via online wine tasting, just as the battle over pesticides reduction proposed by the European Green Deal heats up. But does this event comply with existing rules on lobbying gifts and events targeting MEPs?

A detailed summary of the findings and conclusions of two extensive reports on research public-private partnerships in the EU: the Innovative Medicines Initiative (IMI) and the Bio-Based Industries (BBI) Joint Undertakings.

Despite strong calls from MEPs and the public, ExxonMobil and its lobby groups mobilise enough behind-the-scenes pressure to stop the European Parliament taking away its lobby badges

In this new episode of EU Watchdog Radio, we start with a Bang. This podcast deals with the question how the big digital corporations and platforms like Facebook, Google, Amazon and others try to influence European policy making to keep their business models intact.

New research by Corporate Europe Observatory and LobbyControl shows that Big Tech has spent record sums of money to lobby EU institutions. The report shows that the digital industry now spends nearly €100 million on lobbying, a sum which dwarfs all other lobby spending by the private sector. This lobby surge comes as the EU discusses more stringent regulations on tech companies via the Digital Services Act (DSA) and the Digital Markets Act (DMA).

As Big Tech’s market power has grown, so has its political clout. Just as the EU tries to rein in the most problematic aspects of Big Tech – from disinformation, targeted advertising to excessive market power – the digital giants are lobbying hard to shape new regulations.

In this special Summer episode we bring you the true story of how the EU has been dealing with the covid-19 pandemic so far and why it seems to have a deep love affair with Big Pharma.

New research by Corporate Europe Observatory shows how a behind-the-scenes Council 'working party' which plays a key role in preparing the positions that member states take in the Council on proposed EU laws and policies is offering privileged access to corporate interests.

A secretive Council working party allows corporate lobbyists to influence policy positions. New research by Corporate Europe Observatory into this little scrutinised channel shows how business priorities – such as demands for deregulation – are given a privileged hearing by officials whilst public interest voices are shut out.